Serum tumor markers for screening and early diagnosis of ovarian cancer

Serum tumor markers for screening and early diagnosis of ovarian cancer

Descoperirea de noi biomarkeri sau paneluri de biomarkeri pentru diagnosticarea precoce a cancerului ovarian este una dintre marile provocări ale medicinei moderne. Folosirea determinării de CA125 (biomarkerul cel mai des folosit) a fost îmbunătăţită luând în considerare valorile în dinamică, dispon...

Full description

Bibliographic Details
Main Authors:	Olaru Octavian Gabriel J., Pena Cătălina Monica C.
Format:	Article
Language:	English
Published:	Sciendo 2013-12-01
Series:	Romanian Journal of Laboratory Medicine
Subjects:	ovarian cancer early diagnosis serum biomarkers or serum tumor markers sensitivity specificity cancer ovarian diagnostic precoce markeri tumorali serici sensibilitate specificitate
Online Access:	https://doi.org/10.2478/rrlm-2013-0046

Similar Items

Intérêt de la cytoponction à l'aiguille fine dans le diagnostic des tumeurs parotidiennes
by: Rachida Bouatay, et al.
Published: (2019-05-01)

An Assessment of Serum Selenium Concentration in Women with Ovarian Cancer
by: Marek Kluza, et al.
Published: (2023-02-01)

Utilisation de l'echographie doppler couleur dans la localisation de l'insertion du cordon ombilical et le devenir materno-foetal à la maternité de l'hôpital central de Yaoundé : une étude descriptive et analytique
by: Jeanne Hortence Fouedjio, et al.
Published: (2014-01-01)

Validation of Candidate Serum Ovarian Cancer Biomarkers for Early Detection
by: Feng Su, et al.
Published: (2007-01-01)

Evaluation de la performance du test GoldMag SARS-CoV-2 IgG/IgM dans la détection des Immunoglobulines G chez les patients COVID-19 au Centre de Traitement Epidémiologique de Gbessia
by: Alimou Camara, et al.
Published: (2022-04-01)

Evaluation de la performance du test GoldMag SARS-CoV-2 IgG/IgM dans la détection des Immunoglobulines G chez les patients COVID-19 au Centre de Traitement Epidémiologique de Gbessia
by: Alimou Camara, et al.
Published: (2022-04-01)

Comparison of Serum and Urine as Sources of miRNA Markers for the Detection of Ovarian Cancer
by: Tomas Kupec, et al.
Published: (2023-09-01)

Comprehensive analysis of serum tumor markers and BRCA1/2 germline mutations in Chinese ovarian cancer patients
by: Hongyu Deng, et al.
Published: (2019-06-01)

Diagnostic Value of Serum Levels of Vascular Endothelial Growth Factor as a Marker of Tubal Pregnancy
by: Flora Saghafi, et al.
Published: (2020-02-01)

Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer
by: Asami Ikeda, et al.
Published: (2020-11-01)

Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis
by: Yuan Li, et al.
Published: (2023-02-01)

Potential of osteopontin in the management of epithelial ovarian cancer
by: Cerne Katarina, et al.
Published: (2019-01-01)

Efficacité de l’outil CANRISK pour détecter la dysglycémie chez les membres des Premières Nations et les Métis au Canada
by: Gina Agarwal, et al.
Published: (2018-01-01)

Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer
by: Ying Ying Su, et al.
Published: (2019-01-01)

The Impact of Controlled Ovarian Stimulation on Serum Oxidative Stress Markers in Infertile Women with Endometriosis Undergoing ICSI
by: Michele Gomes Da Broi, et al.
Published: (2022-06-01)

Histopathological Study of Ovarian Lump and Serum Tumor Marker Ca 125 estimation as a Screening Tool
by: Manish Kumar Das, et al.
Published: (2018-08-01)

Combination of serum lipids and cancer antigens as a novel marker for colon cancer diagnosis
by: Tong Li, et al.
Published: (2018-11-01)

ADAM17—A Potential Blood-Based Biomarker for Detection of Early-Stage Ovarian Cancer
by: Christoph Rogmans, et al.
Published: (2021-11-01)

Changes in Nucleolin Expression during Malignant Transformation Leading to Ovarian High-Grade Serous Carcinoma
by: Elizabeth A. Paris, et al.
Published: (2023-01-01)

Serum inhibin B in polycystic ovary syndrome as a potential marker of ovarian dysfunction
by: Ćetković Aleksandar
Published: (2008-01-01)

Serum Anti-PDLIM1 Autoantibody as Diagnostic Marker in Ovarian Cancer
by: Cuipeng Qiu, et al.
Published: (2021-08-01)

Serum HER2 Level in Epithelial Ovarian Cancer
by: Ahmad Monabati, et al.
Published: (2010-04-01)

Gancao Nurish-Yin Decoction medicated serum inhibits growth and migration of ovarian cancer cells: Network pharmacology-based analysis and biological validation
by: Rongbin Pan, et al.
Published: (2022-03-01)

Noninvasive serum N-glycans associated with ovarian cancer diagnosis and precancerous lesion prediction
by: Si Liu, et al.
Published: (2024-01-01)

Inflammation Control and Tumor Growth Inhibition of Ovarian Cancer by Targeting Adhesion Molecules of E-Selectin
by: Bowen Yang, et al.
Published: (2023-04-01)

Estimation Of Serum Vitamin D Levels In Patients with Polycystic Ovarian Syndrome
by: Ruchi Kumari, et al.
Published: (2024-01-01)

Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer
by: Kazuya Maeda, et al.
Published: (2020-04-01)

Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women
by: Autelitano Dominic J, et al.
Published: (2012-03-01)

Serum amyloid a, a potential biomarker both in serum and tissue, correlates with ovarian cancer progression
by: Ze Li, et al.
Published: (2020-06-01)

Comparison of Interleukin-6 with Other Markers in Diagnosis of Ovarian Cancer
by: Magdalena Bizoń, et al.
Published: (2023-06-01)

Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries
by: Felix Rückert, et al.
Published: (2010-06-01)

TUMOR MARKERS IN OVARIAN CANCER
by: Adina-Elena Nenciu, et al.
Published: (2020-09-01)

Inhibin as a tumor marker of ovarian cancer in postmenopausal women
by: Modarres Gilani M, et al.
Published: (2010-05-01)

A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer
by: Stefan Enroth, et al.
Published: (2018-12-01)

HPLC for simultaneous quantification of free mannose and glucose concentrations in serum: use in detection of ovarian cancer
by: Yulong Chen, et al.
Published: (2023-11-01)

IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer
by: Mosig Rebecca A, et al.
Published: (2012-01-01)

Serum Biomarkers for Early Detection of Gynecologic Cancers
by: Yutaka Ueda, et al.
Published: (2010-06-01)

A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass
by: Wegdam Wouter, et al.
Published: (2012-07-01)

Diagnostic Value of the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Thrombocytosis in the Preoperative Investigation of Ovarian Masses
by: Adriana Yoshida, et al.

COMPARATIVE CHARACTERISTICS OF THE AVAILABLE LABORATORY TESTS AND THEIR COMBINATIONS USED IN DIFFERENTIAL DIAGNOSIS OF OVARIAN NEOPLASMS
by: M. A. Egunova, et al.
Published: (2018-02-01)